ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome (CARE-PWS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03649477
Recruitment Status : Recruiting
First Posted : August 28, 2018
Last Update Posted : November 20, 2018
Sponsor:
Information provided by (Responsible Party):
Levo Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2020